LINKER-MM3

A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/Refractory Multiple Myeloma

Near Add Your Location

Sorting 10 by

UCLA Medical Center of Hematology/Oncology
Los Angeles, CA
  • Accepting patients
  • Show Principal Investigator
Norton Cancer Institute (St. Matthews)
St. Matthews Campus
Louisville, KY
  • Accepting patients
  • Show Principal Investigator
Stony Brook University Hospital
Stony Brook, NY
  • Accepting patients
  • Show Principal Investigator
Kaiser Permanente Northwest
Portland, OR
  • Accepting patients
  • Show Principal Investigator
Fred Hutchinson Cancer Research Center
University of Washington Cancer Consortium / SCCA
Seattle, WA
  • Accepting patients
  • Show Principal Investigator
Atrium Health's Levine Cancer Institute - Charlotte (Main)
Atrium Health
Charlotte, NC
  • Accepting patients
  • Show Principal Investigator
Duke Cancer Center
Duke University Medical Center
Durham, NC
  • Accepting patients
  • Show Principal Investigator
UK Markey Cancer Center
University of Kentucky
Lexington, KY
  • Accepting patients
  • Show Principal Investigator
MD Anderson Cancer Center
The University of Texas
Houston, TX
  • Accepting patients
  • Show Principal Investigator
Princess Margaret Cancer Centre
University Health Network
Old Toronto, ON
  • Accepting patients
1,364 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.